Day: March 29, 2021

TORONTO and KNOXVILLE, Tenn., March 29, 2021 (GLOBE NEWSWIRE) — Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: SOLR) is pleased to report significant progress at both the project and corporate levels of the Company as it enters the second quarter with a record pipeline of projects and a strong balance sheet to support future growth. Solar Alliance has built a strong backlog of projects under various stages of agreement with combined capital costs totaling approximately US $66 million, consisting of a diversified portfolio of customers and project sizes. The Company continues to build out that backlog of project opportunities by focusing on the high margin sectors of the solar industry – residential developers and builders, commercial clients, microgrid solutions for larger clients and large scale project...

DURHAM, N.C., March 29, 2021 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies with its ARCUS® genome editing platform, today announced it will participate in the Guggenheim Healthcare Talks 2021 Genomic Medicines & Rare Disease Day on April 1, 2021. Details for the presentation are below: Guggenheim Healthcare Talks | 2021 Genomic Medicines & Rare Disease DayPanel: On the Cusp of Genomic Medicine and Cell Therapy for Dyslipidemia and T1DMPresenter: Derek Jantz, Ph.D., Chief Scientific OfficerDate: Thursday, April 1, 2021Time: 8:00-8:50 AM ET A live webcast of the presentation will be accessible on the Company’s website, www.precisionbiosciences.com, in the Investors & Media section under Events and...

TORONTO, March 29, 2021 (GLOBE NEWSWIRE) — U3O8 Corp. (NEX: UWE.H) (“U3O8” or the “Company”) announces that it has commenced staged test work to determine the efficiency of membranes to recover battery commodities from its Berlin Deposit in Colombia. The objective of the test work is to determine the cost-effectiveness of membrane separation to concentrate battery commodities such as nickel, vanadium and phosphate, among others, as well as uranium, after they have been leached from the mineralized host-rock. Basic Membrane TechnologyMembranes operate like molecular sieves, allowing small molecules to pass through, while retaining larger molecules. The size of molecules that can pass through the membrane is determined by the pore size of the membrane. In potable water production, the general concept is that dirty water is pumped...

SALT LAKE CITY, March 29, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Eric Santa as its new Chief Growth Officer. In this role, he will be responsible for accelerating growth initiatives and building commercial capabilities, and digital platforms to better serve patients and healthcare providers, while driving increased market demand for the company’s portfolio of existing and new products and services. Santa, who reports directly to Paul J. Diaz, president and CEO of Myriad Genetics, brings proven healthcare expertise spanning consumer and digital businesses, as well as commercial transformation, portfolio management, and new growth channels. He previously served as Chief Revenue Officer of Rally Health, Inc., a division of Optum within UnitedHealth...

~ Independent investigation shows that etranacogene dezaparvovec is highly unlikely to be the causeof HCC in HOPE-B pivotal trial ~ ~ Data from investigation submitted to U.S Food and Drug Administration (FDA) on March 26, 2021 ~ LEXINGTON, Mass. and AMSTERDAM, The Netherlands, March 29, 2021 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, announced today the results of a comprehensive investigation into the case of hepatocellular carcinoma (HCC) diagnosed in one patient in the HOPE-B pivotal trial of etranacogene dezaparvovec. The results of the investigation found that it is highly unlikely the HCC was caused by etranacogene dezaparvovec. Multiple analyses conducted by an independent laboratory and reviewed by leading external...

VANCOUVER, British Columbia., March 29, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it has been added to the Horizons Psychedelic Stock Index ETF (“PSYK”) in its first quarterly rebalance of holdings. PSYK (PSYK: NEO) is the world’s first ETF (Exchange Traded Fund) offering direct exposure to North American publicly listed securities that have significant business activities in, or significant exposure to, the psychedelics industry. The underlying index is the North American Psychedelic Stock Index, which is a proprietary index owned and operated by Horizons ETFs, and Solactive AG is the independent calculation agent for the index. “On February 1st, 2021, Algernon...

TORONTO, March 29, 2021 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is pleased to report that activities at its El Gallo Project in Mexico have been restored following successful resolution of the concerns raised by members of the nearby communities. A new 10-year agreement has been reached providing additional support to the communities and greater long-term certainty for the El Gallo operation. ABOUT MCEWEN MININGMcEwen Mining is a diversified gold and silver producer and explorer focused in the Americas with operating mines in Nevada, Canada, Mexico and Argentina. It also owns a large copper deposit in Argentina. The NYSE and TSX have not reviewed and do not accept responsibility for the adequacy or accuracy of the contents of this news release, which has been prepared by management of McEwen Mining Inc.